NDC codes

FDA NDC Directory
Product NDC (as listed)71143-375Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71143-0375Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71143-375-0171143037501711430375011 BOTTLE in 1 CARTON (71143-375-01) / 120 SPRAY, METERED in 1 BOTTLEMarketed from Oct 3, 2017
71143-375-9871143037598711430375981 BOTTLE in 1 CARTON (71143-375-98) / 28 SPRAY, METERED in 1 BOTTLEMarketed from Mar 1, 2019 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Xhance
Generic name (nonproprietary)
fluticasone propionate
Active ingredients
Fluticasone propionate — 93 ug/1
Dosage form
Spray, Metered
Route
Nasal
Labeler
OptiNose US, Inc.NDC labeler code 71143
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 209022
Marketing start
Marketing end
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 71143-375_4650025f-0f79-6a7b-e063-6294a90ab7f6SPL ID 4650025f-0f79-6a7b-e063-6294a90ab7f6SPL set ID c79bbb9f-e483-4093-8c92-ea978e7bf278RxCUI 1946583, 1946589UNII O2GMZ0LF5WUPC 0371143375011
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471143037501 followed by a unit qualifier and the quantity

Package 71143-0375-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

XHANCE is a corticosteroid indicated for the treatment of: Chronic rhinosinusitis with nasal polyps (CRSwNP) in adults. ( 1.1 ) Chronic rhinosinusitis without nasal polyps (CRSsNP) in adults. ( 1.2 ) 1.1 Chronic Rhinosinusitis with Nasal Polyps XHANCE is indicated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults. 1.2 Chronic Rhinosinusitis without Nasal Polyps XHANCE is indicated for the treatment of chronic rhinosinusitis without nasal polyps (CRSsNP) in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71143-375

What is NDC 71143-375?
71143-375 is the product NDC for Xhance (fluticasone propionate), Fluticasone propionate 93 ug/1 spray, metered, listed with the FDA by OptiNose US, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Xhance (Fluticasone propionate).
What is the active ingredient?
Fluticasone propionate.
Who is the labeler?
OptiNose US, Inc., NDC labeler code 71143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Xhance?
1 other product NDC are listed under this name. See all Xhance NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Xhance NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Xhancefluticasone propionateFluticasone propionate 93 ug/1Spray, MeteredNasalParatek Pharmaceuticals, Inc.71715-00371715-0003-3171715-0003-3271715-0003-33

Other NDCs under NDA 209022

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 209022
ProductStrengthForm · routeLabelerProduct NDC
Xhancefluticasone propionateFluticasone propionate 93 ug/1Spray, MeteredNasalParatek Pharmaceuticals, Inc.71715-003

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in